Cargando…

Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis of cancer cells and is verified effective to various cancers. However, a variety of breast cancer cell lines are resistant to TRAIL and the mechanisms of resistance are largely unknown. In our present ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haiji, Xu, Chunyuan, Kong, Xiaoli, Li, Xiaoyan, Kong, Xiangnan, Wang, Yu, Ding, Xia, Yang, Qifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048247/ https://www.ncbi.nlm.nih.gov/pubmed/24905916 http://dx.doi.org/10.1371/journal.pone.0099067

Ejemplares similares

Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer
por: Wang, Haiji, et al.
Publicado: (2019)

53BP1 suppresses epithelial–mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer
por: Kong, Xiangnan, et al.
Publicado: (2015)

miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer
por: Hwang, Michael S., et al.
Publicado: (2013)

The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022)

MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines
por: Liang, Yuan-Ke, et al.
Publicado: (2018)

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
por: Zhou, Yuan, et al.
Publicado: (2020)

miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma
por: Li, Jianguo, et al.
Publicado: (2015)

MiR-221/222 Ameliorates Deoxynivalenol-Induced Apoptosis and Proliferation Inhibition in Intestinal Epithelial Cells by Targeting PTEN
por: Hou, Lianjie, et al.
Publicado: (2021)

miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer
por: Ma, Sisi, et al.
Publicado: (2017)

miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1
por: Liu, Jun, et al.
Publicado: (2015)

PTEN suppresses epithelial–mesenchymal transition and cancer stem cell activity by downregulating Abi1
por: Qi, Yanmei, et al.
Publicado: (2020)

miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition
por: Ren, Haipeng, et al.
Publicado: (2017)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
por: Ye, Xingming, et al.
Publicado: (2014)

HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer
por: Mardente, S., et al.
Publicado: (2015)

MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN
por: Wang, Xudong, et al.
Publicado: (2020)

53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil
por: Li, Xiaoyan, et al.
Publicado: (2013)

CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3
por: Jin, Xiaoxin, et al.
Publicado: (2018)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway
por: Bao, Chang, et al.
Publicado: (2021)

miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin
por: Yang, Lixian, et al.
Publicado: (2022)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

miR-18a Inhibitor Suppresses Leukemia Cell Proliferation by Upregulation of PTEN Expression
por: Zhang, Liping, et al.
Publicado: (2020)

Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder
por: Shorning, Boris Y., et al.
Publicado: (2011)

Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition
por: Tang, Meiling, et al.
Publicado: (2017)

MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1
por: Zhang, Yongtao, et al.
Publicado: (2020)

miR-155 promotes proliferation and epithelial-mesenchymal transition of MCF-7 cells
por: Liu, Xiaoyan, et al.
Publicado: (2021)

α5‐nAChR contributes to epithelial‐mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Promotor Hypomethylation Mediated Upregulation of miR-23b-3p Targets PTEN to Promote Bronchial Epithelial-Mesenchymal Transition in Chronic Asthma
por: Guo, Yimin, et al.
Publicado: (2022)

Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Dong, Shuying, et al.
Publicado: (2015)

miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN
por: Gong, Zhen-Hua, et al.
Publicado: (2019)

MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017)

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
por: Liu, Haizhi, et al.
Publicado: (2017)

miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transition
por: Yu, Yue, et al.
Publicado: (2018)

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
por: Chen, Shu-peng, et al.
Publicado: (2015)

MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
por: Yin, Chonggao, et al.
Publicado: (2018)

miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s6h9pes893jp7c2c7c3lpmgr5b